A QI project based on the results from the retrospective EA/TEF study is underway.

Nonoperative treatment of appendicitis
Emergency Department aspiration of spontaneous pneumothorax
Esophageal atresia and TEF
Development of a predictive index of continence in children with anorectal malformations
Retrospective analysis of congenital lung lesions
Natural history of patent processus vaginalis in Infants
Operative vs. non-operative approach to gastroschisis reduction
Reducing the rate of oophorectomy in the setting of benign disease
Management of breast masses
Optimal management of pilonidal disease in adolescents

Current Areas of Study

Studies to evaluate a protocol which optimizes management of adolescents with spontaneous pneumothorax and to correlate radiographic and other data to long term outcome in newborns with anorectal malformations is almost complete.

Close to 500 patients are in a database of congenital lung lesions.

Contact Us

Consortium News

MWPSC is performing a patient choice study evaluating antibiotics versus operation in the setting of acute appendicitis. This study is supported by a $2.7 million PCORI grant.

We are a group of Pediatric Surgery investigators from academic health centers in the Midwest who are passionate about studying surgical diseases and their management in children. Learn More

Meet the Investigators

Midwest Pediatric Surgery Consortium

3333 Burnet Avenue
Cincinnati, Ohio 45229-3039
513-803-4239

A study on the management of breast masses in pediatric patients is beginning.

Midwest Pediatric Surgery Consortium

A study evaluating the natural history of a patent processus vaginalis (PPV) found during a laparoscopic pyloromyotomy is enrolling patients.

The Thrasher Research Fund has awarded $394,000 to the MWPSC to prospectively study an algorithm for the management of benign ovarian masses in children.

Call Us: +1.7347646482

Beth A. Rymeski, DO
Cincinnati Children's Hosiptal Medical Center, Cincinnati, OH
Current Management of Pediatric Pilonidal Disease: A Perspective Multicenter Surgeon-Choice Cohort Study

Awarded $25,000